185 related articles for article (PubMed ID: 11770280)
1. [Alternatives to hormonal treatment for the prevention of postmenopausal osteoporosis: the bisphosphonates].
Trémollières F
Gynecol Obstet Fertil; 2001 Nov; 29(11):846-52. PubMed ID: 11770280
[No Abstract] [Full Text] [Related]
2. Bisphosphonates.
Diez-Perez A
Maturitas; 2002 Aug; 43 Suppl 1():S19-26. PubMed ID: 12361885
[No Abstract] [Full Text] [Related]
3. Bisphosphonates for osteoporosis.
Drug Ther Bull; 2001 Sep; 39(9):68-72. PubMed ID: 11586803
[TBL] [Abstract][Full Text] [Related]
4. Gastroenterologists and choosing the right bisphosphonate.
Leder BZ; Kronenberg HM
Gastroenterology; 2000 Sep; 119(3):866-9. PubMed ID: 10982780
[No Abstract] [Full Text] [Related]
5. Treating osteoporosis in post-menopausal women: a case approach.
Keller MI
Cleve Clin J Med; 2004 Oct; 71(10):829-37. PubMed ID: 15529489
[TBL] [Abstract][Full Text] [Related]
6. Role of alendronate and risedronate in preventing and treating osteoporosis.
Peters ML; Leonard M; Licata AA
Cleve Clin J Med; 2001 Nov; 68(11):945-51. PubMed ID: 11718433
[TBL] [Abstract][Full Text] [Related]
7. Prevention and treatment of osteoporosis.
Lloyd M
Clin Med (Lond); 2001; 1(2):155-6. PubMed ID: 11333463
[No Abstract] [Full Text] [Related]
8. [Osteoporosis therapy. Bisphosphonates compared].
MMW Fortschr Med; 2003 Mar; 145(13):60. PubMed ID: 15101545
[No Abstract] [Full Text] [Related]
9. [Osteoporosis].
Bartl R
Internist (Berl); 2002 Dec; 43(12):1529-30, 1533-43. PubMed ID: 12607392
[No Abstract] [Full Text] [Related]
10. Clinical pharmacology of potent new bisphosphonates for postmenopausal osteoporosis.
Chapurlat RD
Treat Endocrinol; 2005; 4(2):115-25. PubMed ID: 15783248
[TBL] [Abstract][Full Text] [Related]
11. An approach to postmenopausal osteoporosis treatment: a case study review.
Kessenich C
J Am Acad Nurse Pract; 2003 Dec; 15(12):539-45. PubMed ID: 14983569
[TBL] [Abstract][Full Text] [Related]
12. Treatment of osteoporosis with bisphosphonates.
Watts NB
Rheum Dis Clin North Am; 2001 Feb; 27(1):197-214. PubMed ID: 11285996
[TBL] [Abstract][Full Text] [Related]
13. Use of highly potent bisphosphonates in the treatment of osteoporosis.
McClung M
Curr Osteoporos Rep; 2003 Dec; 1(3):116-22. PubMed ID: 16036074
[TBL] [Abstract][Full Text] [Related]
14. Optimizing administration of bisphosphonates in women with postmenopausal osteoporosis.
Rackoff PJ; Sebba A
Treat Endocrinol; 2005; 4(4):245-51. PubMed ID: 16053341
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic options: an evidence-based approach to prevention and treatment of osteoporosis.
Miller E
Int J Fertil Womens Med; 2003; 48(3):122-6; discussion 137-8. PubMed ID: 12839143
[TBL] [Abstract][Full Text] [Related]
16. Fracture prevention in postmenopausal women.
Mosekilde L; Vestergaard P; Langdahl B
Clin Evid; 2006 Jun; (15):1543-60. PubMed ID: 16973058
[No Abstract] [Full Text] [Related]
17. Bisphosphonates. A cornerstone of osteoporosis treatment.
Mayo Clin Womens Healthsource; 2007 May; 11(5):1-2. PubMed ID: 17476171
[No Abstract] [Full Text] [Related]
18. [Postmenopausal osteoporosis. Bisphosphonates are not all equal].
MMW Fortschr Med; 2009 Mar; 151(11):46-7. PubMed ID: 19469206
[No Abstract] [Full Text] [Related]
19. Risedronate: a new oral bisphosphonate.
Umland EM; Boyce EG
Clin Ther; 2001 Sep; 23(9):1409-21. PubMed ID: 11589256
[TBL] [Abstract][Full Text] [Related]
20. Canadian consensus on osteoporosis. Preventing osteoporosis among postmenopausal women.
Can Fam Physician; 2003 Apr; 49():487. PubMed ID: 12729244
[No Abstract] [Full Text] [Related]
[Next] [New Search]
